Clincosm LogoSign in Get a demo

alopecia areata

Showing 26 - 50 of 129
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alopecia Areata Trial (Ritlecitinib 20 mg)

Not yet recruiting
  • Alopecia Areata
  • Ritlecitinib 20 mg
  • (no location specified)
Dec 6, 2022

Alopecia Areata Trial in New Haven (Tattoo machine (SOL Nova Device))

Completed
  • Alopecia Areata
  • Tattoo machine (SOL Nova Device)
  • New Haven, Connecticut
    Yale University
Dec 7, 2022

A Single-Site Tissue Repository Providing Annotated Biospecimens

Recruiting
  • Age-Related Macular Degeneration
  • +46 more
  • Specimen sample
  • Waltham, Massachusetts
    Sanguine Biosciences
Nov 22, 2022

Alopecia Areata Trial in Chongqing, Changsha (Jaktinib Hydrochloride Tablets)

Completed
  • Alopecia Areata
  • Jaktinib Hydrochloride Tablets
  • Chongqing, Chongqing, China
  • +1 more
Nov 28, 2022

Alopecia Areata Trial in Alicante (Probiotic mixture, Placebo)

Completed
  • Alopecia Areata
  • Probiotic mixture
  • Placebo
  • Alicante, Spain
    Centro Dermatológico Estético
Oct 26, 2022

Alopecia Areata Trial in Cairo (Bimatoprost 0.03% solution, CO2 fractional laser)

Completed
  • Alopecia Areata
  • Bimatoprost 0.03% solution
  • CO2 fractional laser
  • Cairo, Egypt
    AL-Azhar University Hospital
Oct 26, 2022

Alopecia Areata Trial in Cairo (Trichloroacetic acid)

Completed
  • Alopecia Areata
  • Trichloroacetic acid
  • Cairo, Egypt
  • +1 more
Oct 21, 2022

Alopecia Areata, Alopecia, Alopecia Totalis Trial (EQ101)

Not yet recruiting
  • Alopecia Areata
  • +3 more
  • (no location specified)
Oct 18, 2022

Alopecia Areata Trial (Fractional CO2 laser, Derma pen, Niosome minoxidil)

Not yet recruiting
  • Alopecia Areata
  • Fractional CO2 laser
  • +3 more
  • (no location specified)
Oct 16, 2022

Socio-economic Multifacet Burden of Alopecia Areata and

Not yet recruiting
  • Alopecia Areata
    • Toulouse, France
      Toulouse University hospital
    Oct 17, 2022

    Alopecia Areata Trial in Houston (Placebo, SADBE 5%)

    Recruiting
    • Alopecia Areata
    • Placebo
    • SADBE 5%
    • Houston, Texas
      The University of Texas Health Science Center at Houston
    Oct 11, 2022

    Alopecia Areata Trial in Worldwide (CTP-543, 8 mg BID, CTP-543, 12 mg BID, Placebo, BID)

    Completed
    • Alopecia Areata
    • CTP-543, 8 mg BID
    • +2 more
    • Phoenix, Arizona
    • +62 more
    Sep 28, 2022

    Alopecia Areata Trial in New York, Rochester (Dupilumab, Placebo)

    Not yet recruiting
    • Alopecia Areata
    • New York, New York
    • +1 more
    Sep 20, 2022

    Alopecia Areata, Alopecia Totalis, Alopecia Universalis Trial (BNZ-1, Normal saline)

    Withdrawn
    • Alopecia Areata
    • +2 more
    • (no location specified)
    Sep 14, 2022

    Alopecia Areata Trial in New York (Dupilumab, Placebo)

    Completed
    Has Results
    • Alopecia Areata
    • New York, New York
    • +1 more
    Aug 16, 2022

    Alopecia Areata Trial in Worldwide (PF-06651600, Tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccine,

    Active, not recruiting
    • Alopecia Areata
    • Birmingham, Alabama
    • +148 more
    Aug 17, 2022

    Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced), Alopecia Areata Trial run by the National Institute of

    Recruiting
    • Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced)
    • Alopecia Areata
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    Alopecia Areata Trial in Sohag (Pentoxifylline)

    Recruiting
    • Alopecia Areata
    • Sohag, Egypt
      Sohag University Hospital
    Aug 14, 2022

    Alopecia Areata Trial in Guangzhou (KL130008/Placebo)

    Not yet recruiting
    • Alopecia Areata
    • KL130008/Placebo
    • Guangzhou, Guangzhou, China
      The First Affiliated Hospital of Sun Yat-sen University
    Aug 9, 2022

    Alopecia Areata Trial in Sohag (derma pen)

    Not yet recruiting
    • Alopecia Areata
    • derma pen
    • Sohag, Egypt
      Sohag University Hospital
    Aug 2, 2022

    Alopecia Areata Trial in United States (CTP-543, Placebo)

    Active, not recruiting
    • Alopecia Areata
    • Birmingham, Alabama
    • +38 more
    Jul 26, 2022

    Alopecia Areata Trial in Worldwide (CTP-543)

    Active, not recruiting
    • Alopecia Areata
    • Brest Cedex, Finistere, France
    • +38 more
    Jul 26, 2022

    Alopecia Areata Trial in China (SHR0302, Placebo)

    Recruiting
    • Alopecia Areata
    • Hefei, Anhui, China
    • +31 more
    Jul 21, 2022

    Alopecia Areata Trial in United States (CTP-543, CTP-543 matching )

    Completed
    Has Results
    • Alopecia Areata
    • Irvine, California
    • +12 more
    Jun 27, 2022

    PAI-1 Expression in Non-scarring Hair Loss

    Terminated
    • Androgenetic Alopecia
    • +2 more
      • Chicago, Illinois
        Northwestern University Department of Dermatology
      Jun 7, 2022